Moderna stock surges 160% on vaccine data
MRNA
Statements (4)
- Bearish
Moderna stock price sank after vaccine data leak
- Bearish
Moderna shares fell more than 25% on the news of cancer vaccine data.
- Bearish
Moderna, a pharmaceutical company, lost nearly 25% of its stock price on Wall Street following a leak on social media.
- Bearish
Moderna's stock price plummeted following the release of cancer-vaccine study data on social media.